Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse ICAM5 ELISA Kit (AC3211)
Cat.#: ASET-1800
Specifications
Description Mouse ICAM5 ELISA Kit allows for the in vitro quantitative determination of mouse ICAM5 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.234 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.391-25 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2544 Human beta Arrestin 1 ELISA Kit (AC3955) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-1505 Human Eph Receptor A2 ELISA Kit (AC2916) Quantitative inquiry ASET-1078 Human NPTX2 ELISA Kit (AC2489) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-1614 Human TDP43 ELISA Kit (AC3025) Quantitative inquiry ASET-1736 Mouse Netrin 1 ELISA Kit (AC3147) Quantitative inquiry ASET-1058 Mouse L1CAM ELISA Kit (AC2469) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket